Amy Lewis, MD
About
Biography
Amy B. Lewis, M.D. graduated Summa Cum Laude from the
University of Pennsylvania. She then received her Medical
Degree, with highest honors, from the Yale School of Medicine.
Dr. Lewis moved to the New York area for a medical internship
at Cornell/New York Hospital, and completed her Dermatology
residency at the State University of New York Health and
Science Center in Brooklyn where she acted as Chief Resident.
She returned to Yale for a fellowship in Dermatological Laser
and Reconstructive Surgery. After completing this specialized
training, Dr. Lewis began working in private practice, while
also performing several clinical studies pioneering
Dermatological lasers at the Washington Institute for
Dermatological Laser Surgery. She then settled in Manhattan,
where she has built a premier private practice specializing in
Cosmetic and Laser dermatology. In the summer of 2005, Dr.
Lewis founded a Yale Cosmetic Dermatology Division within the
Dermatologic Surgery Department. She is now a Clinical
Assistant Professor of Dermatology at Yale University School of
Medicine. Dr. Lewis is often quoted or featured in the media,
both on television and in popular magazines. She lectures
frequently at academic meetings and has numerous
publications in her specialty.
Dr Lewis is a Certified Yoga Instructor, registered with
the National Yoga Alliance. She believes that taking care of
oneself is a full body challenge requiring mind/body and, of
course, skin awareness.
Dr. Lewis is also a nationally renowned medical expert and
consultant in the field of cosmetic dermatology.
Appointments
Dermatology
Associate Clinical ProfessorPrimary
Other Departments & Organizations
Education & Training
- Postdoctoral Fellow
- Yale University School of Medicine (1994)
- Chief Resident
- State University of New York Downstate Medical Center, Brooklyn, NY (1993)
- Resident
- State University of New York Downstate Medical Center, Brooklyn, NY (1992)
- Intern
- New York Hospital/Cornell Center (1990)
- MD
- Yale University School of Medicine (1989)
Research
Research at a Glance
Yale Co-Authors
Frequent collaborators of Amy Lewis's published research.
Dhanpat Jain, MD
Publications
2008
Nuclear expression of survivin portends a poor prognosis in Merkel cell carcinoma
Kim J, McNiff JM. Nuclear expression of survivin portends a poor prognosis in Merkel cell carcinoma. Modern Pathology 2008, 21: 764-769. PMID: 18425079, DOI: 10.1038/modpathol.2008.61.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsMerkel cell carcinomaCell carcinomaPoor prognosisInhibition of apoptosisCutaneous Merkel cell carcinomaMedian patient ageAggressive clinical courseExpression of survivinNuclear staining patternClinical coursePatient ageNormal human tissuesPrimary lesionAggressive malignancyFemale ratioClinical managementDifferent human cancersFetal organsStrong immunoreactivityCarcinomaNuclear expressionSurvivin expressionStaining patternExact regulatory mechanismNuclear subcellular localizationCircumscribed palmar hypokeratosis: two cases and a review of the literature
Barry CI, Glusac EJ, Kashgarian M, Gwin K, McNiff JM. Circumscribed palmar hypokeratosis: two cases and a review of the literature. Journal Of Cutaneous Pathology 2008, 35: 484-487. PMID: 18399810, DOI: 10.1111/j.1600-0560.2007.00835.x.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsCD8+ but not CD4+ T cells require cognate interactions with target tissues to mediate GVHD across only minor H antigens, whereas both CD4+ and CD8+ T cells require direct leukemic contact to mediate GVL
Matte-Martone C, Liu J, Jain D, McNiff J, Shlomchik WD. CD8+ but not CD4+ T cells require cognate interactions with target tissues to mediate GVHD across only minor H antigens, whereas both CD4+ and CD8+ T cells require direct leukemic contact to mediate GVL. Blood 2008, 111: 3884-3892. PMID: 18223170, PMCID: PMC2275040, DOI: 10.1182/blood-2007-11-125294.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsMeSH KeywordsAnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesDisease Models, AnimalGraft vs Host DiseaseGraft vs Leukemia EffectHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHumansLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMiceMice, KnockoutMinor Histocompatibility AntigensReceptors, Antigen, T-CellStem Cell TransplantationTransplantation ChimeraTransplantation, HomologousConceptsCD4 cellsT cellsT cell antigen receptorAllogeneic stem cell transplantationMajor histocompatibility complex class IDirect cytolytic actionDistinct effector mechanismsDonor CD4 cellsDonor T cellsStem cell transplantationHistocompatibility complex class IMinor H antigensClass II moleculesComplex class IHost diseaseBCR-ABL cDNAGVHDEffector mechanismsMouse modelCML cellsBone marrowCognate interactionNoncytolytic pathwaysCD8Cytolytic action
2007
Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease
Zheng H, Matte-Martone C, Li H, Anderson BE, Venketesan S, Tan H, Jain D, McNiff J, Shlomchik WD. Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease. Blood 2007, 111: 2476-2484. PMID: 18045967, PMCID: PMC2234071, DOI: 10.1182/blood-2007-08-109678.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsMeSH KeywordsAnimalsBone Marrow TransplantationCD4-Positive T-LymphocytesGraft vs Host DiseaseGraft vs Leukemia EffectHematopoietic Stem Cell TransplantationHistocompatibility TestingImmunologic MemoryLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte TransfusionMajor Histocompatibility ComplexMiceTransplantation, HomologousConceptsDonor T cellsT cellsHost diseaseAllogeneic hematopoietic stem cell transplantationFunctional T-cell memoryPerforin-deficient T cellsT-cell-depleted allograftsEffector memory T cellsHematopoietic stem cell transplantationDirect cytolytic functionNonmalignant host tissuesEffector memory CD4Memory T cellsStem cell transplantationT cell memoryBlast crisis chronic myelogenous leukemiaRelevant mouse modelChronic myelogenous leukemiaApplicable cell therapyRecipient alloantigensImmune reconstitutionLeukemia effectMemory CD4Chronic phaseCell transplantation
2001
Treatment of acne scarring.
Hirsch RJ, Lewis AB. Treatment of acne scarring. Seminars In Cutaneous Medicine And Surgery 2001, 20: 190-8. PMID: 11594674, DOI: 10.1053/sder.2001.27557.Peer-Reviewed Original Research
Others
- Lewis, A.B. Laser Resurfacing in the Periocular Region. In: H.M. Spinelli, ed. Atlas of Aesthetic Eyelid and Periocular Surgery. Philadelphia: W.B. Saunders, 2004.Peer-Reviewed Original Research
- Lewis, A.B. Alpha-Hydroxy Acids. In: S. Wolverton, ed. Comprehensive Dermatologic Drug Therapy. Philadelphia: WB Saunders 2001.Peer-Reviewed Original Research
Get In Touch
Contacts
Academic Office Number
Appointment Number
Office Fax Number
Clinic Fax Number